Title-effectiveness and safety of Danshen injection for acute kidney injury in primary nephrotic syndrome.

In this real-world retrospective study of PNS with AKI patients, Danshen injection following immunosuppressive therapy and prophylactic anticoagulation with low molecular heparin significantly increased 6-month partial renal function recovery and had a safety profile. Further randomized clinical trials are warranted to confirm the benefit of Danshen (<i>Radix Salviae Miltiorrhizae</i>) in these patients.